Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-13

Clinical Trial Update: Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 study evaluating topical 10% metronidazole ointment for active perianal Crohn's disease has completed (status: COMPLETED) according to the trial record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical metronidazole 10% ointment (metronidazole)

Snippet

Sponsor: S.L.A. Pharma AG | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED